Advisornet Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$440 Buy
8
+4
+100% +$220 ﹤0.01% 2051
2025
Q1
$283 Sell
4
-2
-33% -$142 ﹤0.01% 2023
2024
Q4
$394 Buy
+6
New +$394 ﹤0.01% 1796
2024
Q2
Sell
-10
Closed -$873 2075
2024
Q1
$873 Sell
10
-386
-97% -$33.7K ﹤0.01% 1793
2023
Q4
$38.2K Buy
396
+9
+2% +$868 ﹤0.01% 892
2023
Q3
$34.2K Sell
387
-118
-23% -$10.4K ﹤0.01% 883
2023
Q2
$43.8K Sell
505
-2,128
-81% -$184K ﹤0.01% 848
2023
Q1
$256K Sell
2,633
-6,828
-72% -$664K 0.02% 424
2022
Q4
$979K Buy
9,461
+26
+0.3% +$2.69K 0.1% 205
2022
Q3
$800K Buy
9,435
+125
+1% +$10.6K 0.08% 240
2022
Q2
$772K Buy
9,310
+360
+4% +$29.9K 0.08% 246
2022
Q1
$690K Buy
8,950
+1,418
+19% +$109K 0.04% 312
2021
Q4
$665K Buy
7,532
+758
+11% +$66.9K 0.04% 341
2021
Q3
$524K Buy
6,774
+717
+12% +$55.5K 0.04% 357
2021
Q2
$505K Buy
6,057
+331
+6% +$27.6K 0.03% 378
2021
Q1
$432K Buy
5,726
+905
+19% +$68.3K 0.03% 387
2020
Q4
$423K Buy
4,821
+115
+2% +$10.1K 0.03% 369
2020
Q3
$358K Hold
4,706
0.03% 389
2020
Q2
$580K Hold
4,706
0.05% 312
2020
Q1
$398K Buy
4,706
+580
+14% +$49.1K 0.04% 353
2019
Q4
$349K Hold
4,126
0.03% 394
2019
Q3
$278K Hold
4,126
0.03% 438
2019
Q2
$353K Buy
4,126
+778
+23% +$66.6K 0.04% 363
2019
Q1
$297K Sell
3,348
-138
-4% -$12.2K 0.04% 369
2018
Q4
$297K Buy
3,486
+7
+0.2% +$596 0.04% 335
2018
Q3
$337K Sell
3,479
-160
-4% -$15.5K 0.04% 329
2018
Q2
$343K Hold
3,639
0.05% 297
2018
Q1
$295K Hold
3,639
0.04% 323
2017
Q4
$324K Buy
+3,639
New +$324K 0.05% 266